
Overview
Icn Polfa Rzeszów is a pharmaceutical company that focuses on producing high-quality medications with therapeutic efficacy. The company aims to meet customer expectations by providing professional services in the pharmaceutical sector. Additionally, it emphasizes ethical practices and social responsibility within regional and global communities.
- ul. Marynarska 15, 02-674 Warszawa
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $983,783 |
Filing timeliness
4 of 6 financial statements were filed late (the longest delay 158 days for 2021). All were audited by a statutory auditor.
- 202522/06/2026
- 202401/07/2025
- 202302/12/2024
- 202213/09/2023
- 202120/12/2022
- 202026/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
- Manufacture of basic pharmaceutical products (21.1)
- Manufacture of other food products (10.8)
Offer
- Medicines
- Pharmaceutical products
- Pharmaceutical services
Websites
The site is available in: Polish and English.
- icnpolfa.plStrona główna – ICN Polfa Rzeszów S.A.Google AnalyticsGoogle Tag ManagerCloudflare
Trademarks
The company currently holds no active trademarks with the Polish Patent Office. 32 marks have expired or were not registered. The first mark was filed in 1992.
| Mark | Protected until | |
|---|---|---|
| EFUDIX (word) | – | |
| VALEZAAR (word) | – | |
| HIPOTENS (word) | – | |
| LAVAXIN (word) | – | |
| valperal (word) | – |
Job offers
The company has its own careers page: icnpolfa.pl/praca.
Authorized Representatives
Manner of representation
President of the Management Board independently, or two members of the management board acting jointly, or a member of the management board with a commercial proxy.
Supervisory board
Ownership
| Owner |
|---|
Bausch+lomb Ops B.v. |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1993-07-05.
91 1030 1250 0000 0000 0904 9201
26 1030 1250 0000 0000 0904 9207
38 1030 1250 0000 0000 0904 9282
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $475.5K$475,479 |
Buildings and premises | $12.2M$12,248,722 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Oct 30, 2012 | Commercial Companies Code notice | |
| Sep 5, 2012 | Commercial Companies Code notice |
Public aid
8 public aid cases recorded, with a total value of $637,692.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 23, 2024 | Aid to cover additional costs related to an exceptionally significant increase in natural gas and electricity prices as a result of the war in Ukraine | –– | Prezes Zarządu Narodowego Funduszu Ochrony Środowiska i Gospodarki Wodnej | |
| Oct 25, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | STAROSTA POWIATU RZESZÓW | |
| Mar 21, 2024 | Aid to cover additional costs related to an exceptionally significant increase in natural gas and electricity prices as a result of the war in Ukraine | –– | Prezes Zarządu Narodowego Funduszu Ochrony Środowiska i Gospodarki Wodnej |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| Waste generation | Active | ||
| Integrated permit | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo Farmaceutyczne S.A. | $160,174,284.28 | anpharm.pl | ||
| Delpharm Poznań S.A. | $110,900,246.81 | delpharm.com | ||
| Tarchomińskie Zakłady Farmaceutyczne Polfa S.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| Natur Produkt Pharma sp. z o.o. | $93,854,070.54 | nppharma.pl | ||
| Orifarm Manufacturing Poland sp. z o.o. | $83,999,052.46 | orifarm.com | ||
| Synoptis Pharma sp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| Wörwag Pharma Operations sp. z o.o. | $46,828,794.87 | woerwagpharma.pl | ||
| Phytopharm Klęka S.A. | $46,154,888.31 | phytopharm.pl | ||
| Silesian Pharma sp. z o.o. | $20,207,433.45 | silesianpharma.pl | ||
| Przedsiębiorstwo Produkcyjno-Handlowe Ewa S.A. | $14,322,437.53 | ewa-sa.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-03-03 | Address change (Przemysłowa 2, 35-959, Rzeszów → Ul. Przemysłowa 2, 35-105, Rzeszów) | |
| 2003-12-22 | Share capital increase (74,801,170.00 PLN → 83,971,520.00 PLN) | |
| 2002-10-16 | Share capital increase (61,617,170.00 PLN → 74,801,170.00 PLN) | |
| 2002-01-24 | Entered in the register |
FAQ
Last updated: 2026-08-25